We are live on ! Find out more
NFC

Northeast Financial Consultants Portfolio holdings

AUM $2.45B
1-Year Est. Return 15.14%
This Fund
S&P 500
This Quarter Est. Return
+1.61%
1 Year Est. Return
+15.14%
3 Year Est. Return
+63.77%
5 Year Est. Return
+108.46%
10 Year Est. Return
+198.58%
AUM
$224M
AUM Growth
-$12.9M
Cap. Flow
-$13M
Cap. Flow %
-5.81%
Top 10 Hldgs %
52.24%
Holding
160
New
4
Increased
29
Reduced
36
Closed
16

Sector Composition

Rank Sector Weight
1 Healthcare 29.08%
2 Energy 9.64%
3 Financials 5.45%
4 Communication Services 4.57%
5 Technology 4.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GBDC icon
126
Golub Capital BDC
GBDC
$3.41B
$246K 0.11%
13,671
+2,552
+23% +$45.7K
ITW icon
127
Illinois Tool Works
ITW
$83.9B
$245K 0.11%
2,000
RYAAY icon
128
Ryanair
RYAAY
$30.9B
$244K 0.11%
7,313
MHD icon
129
BlackRock MuniHoldings Fund
MHD
$604M
$243K 0.11%
15,000
MYN icon
130
BlackRock MuniYield New York Quality Fund
MYN
$376M
$241K 0.11%
19,000
HON icon
131
Honeywell
HON
$77B
$232K 0.1%
2,214
-12
-0.5% -$1.22K
IWF icon
132
iShares Russell 1000 Growth ETF
IWF
$127B
$231K 0.1%
8,816
PKW icon
133
Invesco BuyBack Achievers ETF
PKW
$1.77B
$227K 0.1%
4,500
-400
-8% -$19.6K
RSP icon
134
Invesco S&P 500 Equal Weight ETF
RSP
$99.1B
$217K 0.1%
2,500
IXC icon
135
iShares Global Energy ETF
IXC
$2.72B
$209K 0.09%
6,000
-6,350
-51% -$214K
MRK icon
136
Merck
MRK
$323B
$206K 0.09%
3,673
-629
-15% -$36.8K
PGX icon
137
Invesco Preferred ETF
PGX
$3.76B
$195K 0.09%
13,730
BCRX icon
138
BioCryst Pharmaceuticals
BCRX
$2.51B
$127K 0.06%
20,000
IMGN
139
DELISTED
Immunogen Inc
IMGN
$70K 0.03%
34,315
CFRX
140
DELISTED
ContraFect Corporation
CFRX
$29K 0.01%
21
IRD
141
Opus Genetics
IRD
$302M
$21K 0.01%
313
DARE icon
142
Dare Bioscience
DARE
$20.4M
$14K 0.01%
167
CFRXW
143
DELISTED
ContraFect Corporation Class A Warrants
CFRXW
$1K ﹤0.01%
16,667
ACWI icon
144
iShares MSCI ACWI ETF
ACWI
$33.3B
-3,499
Closed -$207K
ALLE icon
145
Allegion
ALLE
$14.1B
-19,265
Closed -$1.33M
CXT icon
146
Crane NXT
CXT
$2.96B
-44,337
Closed -$970K
DLB icon
147
Dolby
DLB
$5.82B
-4,369
Closed -$237K
FMC icon
148
FMC
FMC
$1.31B
-36,665
Closed -$1.54M
IWD icon
149
iShares Russell 1000 Value ETF
IWD
$84.2B
-3,169
Closed -$335K
MDT icon
150
Medtronic
MDT
$114B
-2,585
Closed -$223K

Similar funds

Northeast Financial Consultants's Q4 2016 Portfolio in Review

As of Q4 2016, Northeast Financial Consultants held 160 positions worth $224M, down 5.5% from $237M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Northeast Financial Consultants withdrew a net $13M in Q4 2016, closing 16 positions and reducing 36 holdings. Its most notable exit was Trane Technologies, an estimated $1.69M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 29% a quarter earlier, followed by Energy and Financials.

Against the trend, Northeast Financial Consultants opened a new position in Avangrid, Inc. worth $1.13M.

  • Northeast Financial Consultants's largest Q4 2016 buy was Avangrid, Inc.: 29,936 shares worth $1.13M.
  • Northeast Financial Consultants added most to Vanguard Morningstar Growth ETF in Q4 2016, an estimated $11.1M increase.
  • Northeast Financial Consultants's biggest Q4 2016 reduction was Vulcan Materials, cutting an estimated $5.92M.
  • Northeast Financial Consultants fully exited Trane Technologies in Q4 2016, selling an estimated $1.69M.
  • Northeast Financial Consultants's ten largest holdings make up 52% of its $224M portfolio in Q4 2016.
  • Northeast Financial Consultants opened 4 new positions and closed 16 in Q4 2016.
  • Northeast Financial Consultants's portfolio value fell 5.5% quarter-over-quarter to $224M.

Based on Northeast Financial Consultants's 13F filing for Q4 2016, filed 23 Jan 2017.